Robert E. Funck Jr. - May 10, 2024 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
May 10, 2024
Transactions value $
-$581,260
Form type
4
Date filed
5/14/2024, 05:35 PM
Previous filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $475K +10.1K +4.78% $47.00 221K May 10, 2024 Direct
transaction ABT Common shares without par value Sale -$1.06M -10.1K -4.56% $104.57 211K May 10, 2024 Direct F1
holding ABT Common shares without par value 20K May 10, 2024 By Trust F2
holding ABT Common shares without par value 20K May 10, 2024 By Trust F2
holding ABT Common shares without par value 18.8K May 10, 2024 Profit Sharing Trust F3
holding ABT Common shares without par value 500 May 10, 2024 By Daughter F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -10.1K -18.33% $0.00 45K May 10, 2024 Common Shares 10.1K $47.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.55 to $104.62, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F3 Balance in the Abbott Laboratories Stock Retirement Trust as of May 10, 2024.
F4 The reporting person disclaims beneficial ownership of all securities held by his daughter.
F5 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.